NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors

Table 5

Pharmacokinetics of gemcitabine (cycle 1) and gemcitabine plus mistletoe (cycle 3).

	Cycle 1; Median; (25th%, 75th%)	Cycle 3; Median; (25th%, 75th%)	𝑃 value; Signed rank test
Gemcitabine; AUC (min * nmol/mL)	664; (514, 870)	670; (625, 851)	0.97
Gemcitabine; Average Cp (nmol/mL)	47.7; (42.7, 64.6)	49.7; (45.7, 53.8)	0.85